Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation
Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the presumably “normal-ap...
Gespeichert in:
| Veröffentlicht in: | Current oncology (Toronto) Jg. 28; H. 6; S. 5041 - 5053 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Switzerland
MDPI
01.12.2021
MDPI AG |
| Schlagworte: | |
| ISSN: | 1718-7729, 1198-0052, 1718-7729 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the presumably “normal-appearing” brain following chemoradiation therapy (CRT) in GB patients in comparison to healthy controls. Twenty (seven female, thirteen male) GB patients underwent a 31P-MRS scan prior to surgery (baseline) and after three months of standard CRT (follow-up examination. The regions of interest “contrast-enhancing (CE) tumor” (if present), “adjacent to the (former) tumor”, “ipsilateral distant” hemisphere, and “contralateral” hemisphere were compared, differentiating between patients with stable (SD) and progressive disease (PD). Metabolite ratios PCr/ATP, Pi/ATP, PCr/Pi, PME/PDE, PME/PCr, and PDE/ATP were investigated. In PD, energy and membrane metabolism in CE tumor areas have a tendency to “normalize” under therapy. In different “normal-appearing” brain areas of GB patients, the energy and membrane metabolism either “normalized” or were “disturbed”, in comparison to baseline or controls. Differences were also detected between patients with SD and PD. 31P-MRS might contribute as an additional imaging biomarker for outcome measurement, which remains to be investigated in a larger cohort. |
|---|---|
| AbstractList | Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the presumably “normal-appearing” brain following chemoradiation therapy (CRT) in GB patients in comparison to healthy controls. Twenty (seven female, thirteen male) GB patients underwent a 31P-MRS scan prior to surgery (baseline) and after three months of standard CRT (follow-up examination. The regions of interest “contrast-enhancing (CE) tumor” (if present), “adjacent to the (former) tumor”, “ipsilateral distant” hemisphere, and “contralateral” hemisphere were compared, differentiating between patients with stable (SD) and progressive disease (PD). Metabolite ratios PCr/ATP, Pi/ATP, PCr/Pi, PME/PDE, PME/PCr, and PDE/ATP were investigated. In PD, energy and membrane metabolism in CE tumor areas have a tendency to “normalize” under therapy. In different “normal-appearing” brain areas of GB patients, the energy and membrane metabolism either “normalized” or were “disturbed”, in comparison to baseline or controls. Differences were also detected between patients with SD and PD. 31P-MRS might contribute as an additional imaging biomarker for outcome measurement, which remains to be investigated in a larger cohort. Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the presumably "normal-appearing" brain following chemoradiation therapy (CRT) in GB patients in comparison to healthy controls. Twenty (seven female, thirteen male) GB patients underwent a 31P-MRS scan prior to surgery (baseline) and after three months of standard CRT (follow-up examination. The regions of interest "contrast-enhancing (CE) tumor" (if present), "adjacent to the (former) tumor", "ipsilateral distant" hemisphere, and "contralateral" hemisphere were compared, differentiating between patients with stable (SD) and progressive disease (PD). Metabolite ratios PCr/ATP, Pi/ATP, PCr/Pi, PME/PDE, PME/PCr, and PDE/ATP were investigated. In PD, energy and membrane metabolism in CE tumor areas have a tendency to "normalize" under therapy. In different "normal-appearing" brain areas of GB patients, the energy and membrane metabolism either "normalized" or were "disturbed", in comparison to baseline or controls. Differences were also detected between patients with SD and PD. 31P-MRS might contribute as an additional imaging biomarker for outcome measurement, which remains to be investigated in a larger cohort.Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the presumably "normal-appearing" brain following chemoradiation therapy (CRT) in GB patients in comparison to healthy controls. Twenty (seven female, thirteen male) GB patients underwent a 31P-MRS scan prior to surgery (baseline) and after three months of standard CRT (follow-up examination. The regions of interest "contrast-enhancing (CE) tumor" (if present), "adjacent to the (former) tumor", "ipsilateral distant" hemisphere, and "contralateral" hemisphere were compared, differentiating between patients with stable (SD) and progressive disease (PD). Metabolite ratios PCr/ATP, Pi/ATP, PCr/Pi, PME/PDE, PME/PCr, and PDE/ATP were investigated. In PD, energy and membrane metabolism in CE tumor areas have a tendency to "normalize" under therapy. In different "normal-appearing" brain areas of GB patients, the energy and membrane metabolism either "normalized" or were "disturbed", in comparison to baseline or controls. Differences were also detected between patients with SD and PD. 31P-MRS might contribute as an additional imaging biomarker for outcome measurement, which remains to be investigated in a larger cohort. |
| Author | Steiger, Ruth Grams, Astrid Ellen Radovic, Ivan Mangesius, Julian Nowosielski, Martha Gizewski, Elke Ruth Galijašević, Malik Rietzler, Andreas Freyschlag, Christian Franz Kerschbaumer, Johannes Mangesius, Stephanie Walchhofer, Lisa Maria |
| AuthorAffiliation | 1 Department of Neuroradiology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; astrid.grams@i-med.ac.at (A.E.G.); stephanie.mangeisus@i-med.ac.at (S.M.); ivan.radovic@icloud.com (I.R.); andreas.rietzler@i-med.ac.at (A.R.); malik.galijasevic@i-med.ac.at (M.G.); elke.gizewski@i-med.ac.at (E.R.G.) 4 Department of Radiation Oncology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; julian.mangesius@i-med.ac.at 2 Neuroimaging Core Facility, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria 6 Department of Neurosurgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; christian.freyschlag@i-med.ac.at (C.F.F.); johannes.kerschbaumer@i-med.ac.at (J.K.) 5 Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; martha.nowosielski@i-med.ac.at 3 Department of Radiology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; lisa.walchhof |
| AuthorAffiliation_xml | – name: 3 Department of Radiology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; lisa.walchhofer@kh-schwaz.at – name: 6 Department of Neurosurgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; christian.freyschlag@i-med.ac.at (C.F.F.); johannes.kerschbaumer@i-med.ac.at (J.K.) – name: 2 Neuroimaging Core Facility, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria – name: 1 Department of Neuroradiology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; astrid.grams@i-med.ac.at (A.E.G.); stephanie.mangeisus@i-med.ac.at (S.M.); ivan.radovic@icloud.com (I.R.); andreas.rietzler@i-med.ac.at (A.R.); malik.galijasevic@i-med.ac.at (M.G.); elke.gizewski@i-med.ac.at (E.R.G.) – name: 4 Department of Radiation Oncology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; julian.mangesius@i-med.ac.at – name: 5 Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; martha.nowosielski@i-med.ac.at |
| Author_xml | – sequence: 1 givenname: Astrid Ellen orcidid: 0000-0003-2304-3946 surname: Grams fullname: Grams, Astrid Ellen – sequence: 2 givenname: Stephanie orcidid: 0000-0001-5790-2724 surname: Mangesius fullname: Mangesius, Stephanie – sequence: 3 givenname: Ruth surname: Steiger fullname: Steiger, Ruth – sequence: 4 givenname: Ivan surname: Radovic fullname: Radovic, Ivan – sequence: 5 givenname: Andreas orcidid: 0000-0002-0808-2667 surname: Rietzler fullname: Rietzler, Andreas – sequence: 6 givenname: Lisa Maria surname: Walchhofer fullname: Walchhofer, Lisa Maria – sequence: 7 givenname: Malik orcidid: 0000-0001-6577-0784 surname: Galijašević fullname: Galijašević, Malik – sequence: 8 givenname: Julian orcidid: 0000-0003-0855-1870 surname: Mangesius fullname: Mangesius, Julian – sequence: 9 givenname: Martha orcidid: 0000-0002-8068-315X surname: Nowosielski fullname: Nowosielski, Martha – sequence: 10 givenname: Christian Franz orcidid: 0000-0002-8228-8217 surname: Freyschlag fullname: Freyschlag, Christian Franz – sequence: 11 givenname: Johannes surname: Kerschbaumer fullname: Kerschbaumer, Johannes – sequence: 12 givenname: Elke Ruth surname: Gizewski fullname: Gizewski, Elke Ruth |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34940063$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kk1v1DAQhi1URD9_ABeUI5eFsZ3EzgUJVm2pVMQFJG7W-CNZV45d7Cyo_75ut0UtiIs9M37fZ6TxHJK9mKIj5DWFd5wP8N5sc07RpMAk9NCy9gU5oILKlRBs2HsS75PDUq4AOBdCvCL7vB1agJ4fkB_rDcbJlcbH5lPGep5Gl6ebBqNtvrhZZ4yuBgvqFHyZ73TnwScdsCxpxmZMIaTfPk7NeuPmlNF6XHyKx-TliKG4k4f7iHw_O_22_ry6_Hp-sf54uTJt3y2rkRmgo5UUGR0MtLzlaEccLQ6Gg-xQ1FRrhswZYBR6lP0opOQdGtuB5UfkYse1Ca_UdfYz5huV0Kv7QsqTwrx4E5wCiZpL243WmbbjWrJOSyGHWqUIGirrw451vdWzs8bFJWN4Bn3-Ev1GTemXkgLq-PsKePsAyOnn1pVFzb4YF0IdYtoWxXrK2cCoYFX65mmvP00ev6YKxE5gciolu1EZv9yPtrb2QVFQd0ug_lmC6qR_OR_h__fcAhpPufw |
| CitedBy_id | crossref_primary_10_3390_cancers17010124 crossref_primary_10_3390_cancers14246264 crossref_primary_10_1016_j_neurad_2021_11_006 crossref_primary_10_1007_s40336_022_00502_y crossref_primary_10_25259_SNI_498_2024 crossref_primary_10_1002_jmri_29326 crossref_primary_10_3390_diagnostics14080841 crossref_primary_10_3390_biomedicines11020364 crossref_primary_10_3390_cancers14133197 |
| Cites_doi | 10.1016/j.clineuro.2012.01.026 10.1016/j.neuroimage.2005.12.052 10.1002/jmri.25619 10.3348/kjr.2013.14.3.477 10.1002/nbm.1940050506 10.2174/1570159X14666160121115641 10.1038/jcbfm.1987.106 10.1016/S0167-8140(02)00078-6 10.1016/0014-4827(82)90063-5 10.1212/WNL.39.4.538 10.1002/nbm.735 10.1016/S0735-1097(02)02160-5 10.1200/JCO.2009.26.3541 10.1007/s00062-017-0630-8 10.3390/cancers13143569 10.1007/s10334-008-0148-9 10.1016/j.molcel.2013.01.018 10.1371/journal.pone.0056439 10.1158/1538-7445.AM2020-4803 10.1002/nbm.891 10.3390/cancers13112598 10.1002/nbm.1621 10.1006/jmre.1997.1244 10.1093/brain/awp293 10.1215/S1152851703000620 10.1056/NEJMoa043330 10.1159/000017471 10.1227/00006123-199604000-00026 10.1016/S0021-9258(18)48107-0 10.3174/ajnr.A3702 10.1001/archneurol.2011.2910 10.1111/bdi.12339 10.1038/nrn3765 10.1016/j.ejrad.2013.11.009 10.1002/nbm.1109 10.1002/mrm.20312 10.1177/197140090702000608 10.1093/neuonc/nor132 10.1002/jmri.25278 |
| ContentType | Journal Article |
| Copyright | 2021 by the authors. 2021 |
| Copyright_xml | – notice: 2021 by the authors. 2021 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.3390/curroncol28060424 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1718-7729 |
| EndPage | 5053 |
| ExternalDocumentID | oai_doaj_org_article_08ab38d5fdec453b825b8789ab31a0b0 PMC8700426 34940063 10_3390_curroncol28060424 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Oesterreichische Nationalbank grantid: 15866 |
| GroupedDBID | --- 04C 29F 2WC 53G 5GY 5VS 6PF AAWTL AAYXX ABDBF ACGFS ACUHS ADBBV AENEX AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BMSDO CITATION CS3 DIK DU5 E3Z EBD EBS EIHBH EJD ESX F5P GROUPED_DOAJ HYE KQ8 MODMG OK1 OVT RNS RPM TR2 TUS CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c465t-f2c01fd81a219c04343adfafda9c3085a7adfbb2a2ec02106a86f78835acd50d3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 9 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000736647100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1718-7729 1198-0052 |
| IngestDate | Fri Oct 03 12:29:30 EDT 2025 Thu Aug 21 14:14:37 EDT 2025 Thu Jul 10 18:09:20 EDT 2025 Thu Apr 03 07:09:13 EDT 2025 Tue Nov 18 21:06:59 EST 2025 Thu Oct 16 04:40:13 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | glioblastoma normal-appearing brain tissue tumor infiltration cerebral energy metabolism ATP chemoradiation phosphorous magnetic resonance spectroscopy (31P-MRS) |
| Language | English |
| License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c465t-f2c01fd81a219c04343adfafda9c3085a7adfbb2a2ec02106a86f78835acd50d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Contributed equally, shared first author. |
| ORCID | 0000-0001-6577-0784 0000-0001-5790-2724 0000-0003-0855-1870 0000-0002-0808-2667 0000-0002-8228-8217 0000-0002-8068-315X 0000-0003-2304-3946 |
| OpenAccessLink | https://doaj.org/article/08ab38d5fdec453b825b8789ab31a0b0 |
| PMID | 34940063 |
| PQID | 2613292172 |
| PQPubID | 23479 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_08ab38d5fdec453b825b8789ab31a0b0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8700426 proquest_miscellaneous_2613292172 pubmed_primary_34940063 crossref_citationtrail_10_3390_curroncol28060424 crossref_primary_10_3390_curroncol28060424 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-12-01 20211201 |
| PublicationDateYYYYMMDD | 2021-12-01 |
| PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Current oncology (Toronto) |
| PublicationTitleAlternate | Curr Oncol |
| PublicationYear | 2021 |
| Publisher | MDPI MDPI AG |
| Publisher_xml | – name: MDPI – name: MDPI AG |
| References | Stupp (ref_1) 2005; 352 Metallo (ref_41) 2013; 49 Hattingen (ref_35) 2009; 22 Novak (ref_29) 2014; 83 Sahm (ref_5) 2012; 69 Guntuku (ref_44) 2016; 14 Maintz (ref_21) 2002; 15 Wen (ref_33) 2010; 28 Hattingen (ref_37) 2009; 132 Kemp (ref_14) 2000; 22 Hattingen (ref_36) 2011; 24 Daly (ref_16) 1987; 262 Laperriere (ref_31) 2002; 64 Lin (ref_12) 2016; 44 Ha (ref_19) 2013; 14 Vanhamme (ref_39) 1997; 129 Steiger (ref_34) 2018; 2018 Stark (ref_32) 2012; 114 Lamborn (ref_30) 2004; 6 Albers (ref_15) 2005; 53 Kamble (ref_23) 2014; 8 Hattingen (ref_26) 2011; 13 Lenz (ref_43) 2020; 80 Vink (ref_10) 1987; 7 Scherer (ref_4) 1938; 34 Skog (ref_42) 1982; 141 Stieltjes (ref_8) 2006; 31 Inglese (ref_6) 2006; 27 Sternberg (ref_7) 2014; 35 Welch (ref_13) 1989; 39 ref_20 Wenger (ref_38) 2019; 29 Kreis (ref_40) 2004; 17 Beer (ref_9) 2002; 40 Hnilicova (ref_25) 2020; 121 ref_28 Cohen (ref_17) 1992; 5 Shi (ref_18) 2015; 17 Wenger (ref_24) 2017; 46 ref_27 Chance (ref_11) 2006; 19 Bulakbasi (ref_22) 2007; 20 Giese (ref_2) 1996; 38 Cuddapah (ref_3) 2014; 15 |
| References_xml | – volume: 114 start-page: 840 year: 2012 ident: ref_32 article-title: Glioblastoma: Clinical characteristics, prognostic factors and survival in 492 patients publication-title: Clin. Neurol. Neurosurg. doi: 10.1016/j.clineuro.2012.01.026 – volume: 31 start-page: 531 year: 2006 ident: ref_8 article-title: Diffusion tensor imaging in primary brain tumors: Reproducible quantitative analysis of corpus callosum infiltration and contralateral involvement using a probabilistic mixture model publication-title: Neuroimage doi: 10.1016/j.neuroimage.2005.12.052 – volume: 46 start-page: 1200 year: 2017 ident: ref_24 article-title: Intracellular pH measured by (31) P-MR-spectroscopy might predict site of progression in recurrent glioblastoma under antiangiogenic therapy publication-title: J. Magn. Reson. Imaging JMRI doi: 10.1002/jmri.25619 – volume: 121 start-page: 488 year: 2020 ident: ref_25 article-title: Noninvasive study of brain tumours metabolism using phosphorus-31 magnetic resonance spectroscopy publication-title: Bratisl. Lek. Listy – volume: 14 start-page: 477 year: 2013 ident: ref_19 article-title: Application of 31P MR spectroscopy to the brain tumors publication-title: Korean J. Radiol. doi: 10.3348/kjr.2013.14.3.477 – volume: 5 start-page: 226 year: 1992 ident: ref_17 article-title: Phospholipid metabolites as indicators of cancer cell function publication-title: NMR Biomed. doi: 10.1002/nbm.1940050506 – volume: 14 start-page: 567 year: 2016 ident: ref_44 article-title: Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds publication-title: Curr. Neuropharmacol. doi: 10.2174/1570159X14666160121115641 – volume: 34 start-page: 333 year: 1938 ident: ref_4 article-title: Structural development in gliomas publication-title: Am. J. Cancer – volume: 7 start-page: 563 year: 1987 ident: ref_10 article-title: Effects of traumatic brain injury on cerebral high-energy phosphates and pH: A 31P magnetic resonance spectroscopy study publication-title: J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.1987.106 – volume: 64 start-page: 259 year: 2002 ident: ref_31 article-title: Radiotherapy for newly diagnosed malignant glioma in adults: A systematic review publication-title: Radiother. Oncol. doi: 10.1016/S0167-8140(02)00078-6 – volume: 141 start-page: 23 year: 1982 ident: ref_42 article-title: Energy metabolism and ATP turnover time during the cell cycle of Ehrlich ascites tumour cells publication-title: Exp. Cell Res. doi: 10.1016/0014-4827(82)90063-5 – volume: 2018 start-page: 7806395 year: 2018 ident: ref_34 article-title: Cerebral Phosphorus Magnetic Resonance Spectroscopy in a Patient with Giant Cell Arteritis and Endovascular Therapy publication-title: Case Rep. Radiol. – volume: 39 start-page: 538 year: 1989 ident: ref_13 article-title: Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy publication-title: Neurology doi: 10.1212/WNL.39.4.538 – volume: 15 start-page: 18 year: 2002 ident: ref_21 article-title: Phosphorus-31 MR spectroscopy of normal adult human brain and brain tumours publication-title: NMR Biomed. doi: 10.1002/nbm.735 – volume: 40 start-page: 1267 year: 2002 ident: ref_9 article-title: Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy publication-title: J. Am. Coll. Cardiol. doi: 10.1016/S0735-1097(02)02160-5 – volume: 8 start-page: Rc05 year: 2014 ident: ref_23 article-title: Energy status and metabolism in intracranial space occupying lesions: A prospective 31p spectroscopic study publication-title: J. Clin. Diagn. Res. – volume: 28 start-page: 1963 year: 2010 ident: ref_33 article-title: Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2009.26.3541 – volume: 29 start-page: 27 year: 2019 ident: ref_38 article-title: In vivo Metabolic Profiles as Determined by (31)P and short TE (1)H MR-Spectroscopy: No Difference Between Patients with IDH Wildtype and IDH Mutant Gliomas publication-title: Clin. Neuroradiol. doi: 10.1007/s00062-017-0630-8 – ident: ref_28 doi: 10.3390/cancers13143569 – volume: 22 start-page: 43 year: 2009 ident: ref_35 article-title: Combined 1H and 31P MR spectroscopic imaging: Impaired energy metabolism in severe carotid stenosis and changes upon treatment publication-title: MAGMA doi: 10.1007/s10334-008-0148-9 – volume: 49 start-page: 388 year: 2013 ident: ref_41 article-title: Understanding metabolic regulation and its influence on cell physiology publication-title: Mol. Cell doi: 10.1016/j.molcel.2013.01.018 – ident: ref_20 doi: 10.1371/journal.pone.0056439 – volume: 80 start-page: 4803 year: 2020 ident: ref_43 article-title: Mitochondrial response to temozolomide treatment in glioma cells publication-title: Cancer Res. doi: 10.1158/1538-7445.AM2020-4803 – volume: 17 start-page: 361 year: 2004 ident: ref_40 article-title: Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts publication-title: NMR Biomed. doi: 10.1002/nbm.891 – ident: ref_27 doi: 10.3390/cancers13112598 – volume: 24 start-page: 536 year: 2011 ident: ref_36 article-title: Combined (1)H and (31)P spectroscopy provides new insights into the pathobiochemistry of brain damage in multiple sclerosis publication-title: NMR Biomed. doi: 10.1002/nbm.1621 – volume: 129 start-page: 35 year: 1997 ident: ref_39 article-title: Improved method for accurate and efficient quantification of MRS data with use of prior knowledge publication-title: J. Magn. Reson. doi: 10.1006/jmre.1997.1244 – volume: 132 start-page: 3285 year: 2009 ident: ref_37 article-title: Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson’s disease publication-title: Brain A J. Neurol. doi: 10.1093/brain/awp293 – volume: 6 start-page: 227 year: 2004 ident: ref_30 article-title: Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis publication-title: Neuro. Oncol. doi: 10.1215/S1152851703000620 – volume: 352 start-page: 987 year: 2005 ident: ref_1 article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa043330 – volume: 27 start-page: 2137 year: 2006 ident: ref_6 article-title: Whole-brain N-acetylaspartate spectroscopy and diffusion tensor imaging in patients with newly diagnosed gliomas: A preliminary study publication-title: AJNR Am. J. Neuroradiol. – volume: 22 start-page: 418 year: 2000 ident: ref_14 article-title: Non-invasive methods for studying brain energy metabolism: What they show and what it means publication-title: Dev. Neurosci. doi: 10.1159/000017471 – volume: 38 start-page: 755 year: 1996 ident: ref_2 article-title: Migration of human glioma cells on myelin publication-title: Neurosurgery doi: 10.1227/00006123-199604000-00026 – volume: 262 start-page: 14875 year: 1987 ident: ref_16 article-title: Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)48107-0 – volume: 35 start-page: 439 year: 2014 ident: ref_7 article-title: Utility of diffusion tensor imaging in evaluation of the peritumoral region in patients with primary and metastatic brain tumors publication-title: AJNR Am. J. Neuroradiol. doi: 10.3174/ajnr.A3702 – volume: 69 start-page: 523 year: 2012 ident: ref_5 article-title: Addressing diffuse glioma as a systemic brain disease with single-cell analysis publication-title: Arch. Neurol. doi: 10.1001/archneurol.2011.2910 – volume: 17 start-page: 743 year: 2015 ident: ref_18 article-title: Decreased brain PME/PDE ratio in bipolar disorder: A preliminary (31) P magnetic resonance spectroscopy study publication-title: Bipolar Disord. doi: 10.1111/bdi.12339 – volume: 15 start-page: 455 year: 2014 ident: ref_3 article-title: A neurocentric perspective on glioma invasion publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn3765 – volume: 83 start-page: e106 year: 2014 ident: ref_29 article-title: Clinical protocols for (3)(1)P MRS of the brain and their use in evaluating optic pathway gliomas in children publication-title: Eur. J. Radiol. doi: 10.1016/j.ejrad.2013.11.009 – volume: 19 start-page: 904 year: 2006 ident: ref_11 article-title: Skeletal muscle energetics with PNMR: Personal views and historic perspectives publication-title: NMR Biomed. doi: 10.1002/nbm.1109 – volume: 53 start-page: 22 year: 2005 ident: ref_15 article-title: Proton-decoupled 31P MRS in untreated pediatric brain tumors publication-title: Magn. Reson. Med. doi: 10.1002/mrm.20312 – volume: 20 start-page: 646 year: 2007 ident: ref_22 article-title: Efficacy of in vivo 31Phosphorus Magnetic Resonance Spectroscopy in Differentiation and Staging of Adult Human Brain Tumors publication-title: Neuroradiol. J. doi: 10.1177/197140090702000608 – volume: 13 start-page: 1349 year: 2011 ident: ref_26 article-title: Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: A 31P/1H MRSI and quantitative magnetic resonance imaging study publication-title: Neuro-Oncology doi: 10.1093/neuonc/nor132 – volume: 44 start-page: 1132 year: 2016 ident: ref_12 article-title: MRI assessment of regional differences in phosphorus-31 metabolism and morphological abnormalities of the foot muscles in diabetes publication-title: J. Magn. Reson. Imaging JMRI doi: 10.1002/jmri.25278 |
| SSID | ssj0033777 |
| Score | 2.3051813 |
| Snippet | Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 5041 |
| SubjectTerms | ATP Brain cerebral energy metabolism chemoradiation Chemoradiotherapy Female glioblastoma Glioblastoma - diagnostic imaging Glioblastoma - metabolism Glioblastoma - therapy Humans Magnetic Resonance Imaging Magnetic Resonance Spectroscopy Male normal-appearing brain tissue phosphorous magnetic resonance spectroscopy (31P-MRS) |
| Title | Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34940063 https://www.proquest.com/docview/2613292172 https://pubmed.ncbi.nlm.nih.gov/PMC8700426 https://doaj.org/article/08ab38d5fdec453b825b8789ab31a0b0 |
| Volume | 28 |
| WOSCitedRecordID | wos000736647100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1718-7729 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0033777 issn: 1718-7729 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9QwDLZghRAXxJvyWBWJE1K1adM06ZFFu3BgVxwAza3KU1SaaVczHfj72ElntAMILtzaNFEj20n8yfFngNfa-VBb1RSVMFVRKxcK5UtXBN5YbnQwTcx6__pRXl6qxaL9dK3UF90JS_TASXAnTGnDlRPBeVsLbhDRGCVVi62lZiaidSbbHZhKezDnUqayKpRAxkSV4pkcAf6J3a7X44BSppgiBf4OTqRI3P8nb_PXS5PXTqHze3B3dh_zt2na9-GGHx7A7Ys5QP4QFilbYJP3Q35K1R_ys5jcl-vB5Rd-hdh48Pgwoe6X_WZF_d4v-9GgEz2NK50HtIvxB55nOVEJoH24pLtH8OX87PO7D8VcPKGwdSOmIlSWlcGpUuOeZBklkGoXdHC6tRz9LC3x1ZhKV94S7mu0agLiYS60dYI5_hiOhnHwTyHHbozCfaVtRa0D0RlKg0Nb0TqNDkUGbCfAzs7M4lTgYtkhwiCZd7_JPIM3-yFXiVbjb51PSSv7jsSIHRvQTrrZTrp_2UkGr3Y67XAFUVgEBT5uNx1iSF61VKgrgydJx_tfEXkPeXEZyAPtH8zl8MvQf4ss3UpGfPrsf0z-Odyp6C5NvEbzAo6m9da_hFv2-9Rv1sdwUy7UcVwAPwHmbg0l |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+Brain+Energy+and+Membrane+Metabolism+in+Glioblastoma+following+Chemoradiation&rft.jtitle=Current+oncology+%28Toronto%29&rft.au=Astrid+Ellen+Grams&rft.au=Stephanie+Mangesius&rft.au=Ruth+Steiger&rft.au=Ivan+Radovic&rft.date=2021-12-01&rft.pub=MDPI+AG&rft.issn=1198-0052&rft.eissn=1718-7729&rft.volume=28&rft.issue=6&rft.spage=5041&rft.epage=5053&rft_id=info:doi/10.3390%2Fcurroncol28060424&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_08ab38d5fdec453b825b8789ab31a0b0 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1718-7729&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1718-7729&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1718-7729&client=summon |